Search - tctmd.com

Displaying 1 - 12 of 12

Sort: Relevancy | Date

Heart Failure Doubles Risk of Dying From COVID-19

News Daily News

Heart Failure Doubles Risk of Dying From COVID-19

October 30, 2020

New Review Urges Rethink of Cardiogenic Shock Care

News Daily News

New Review Urges Rethink of Cardiogenic Shock Care

October 27, 2020

Fewer Events and Symptoms With iFR-Optimized PCI, Suggests DEFINE-PCI Trial

News Conference News TCT 2020

Fewer Events and Symptoms With iFR-Optimized PCI, Suggests DEFINE-PCI Trial

Michael O'Riordan

October 17, 2020

Sapien 3 Stroke Rate Perplexes in 1-Year SOLVE-TAVI Results

News Conference News TCT 2020

Sapien 3 Stroke Rate Perplexes in 1-Year SOLVE-TAVI Results

Michael O'Riordan

October 16, 2020

ECMO Registry Data Show Progress in COVID-19

News Daily News

ECMO Registry Data Show Progress in COVID-19

October 01, 2020

TAVR and Infective Endocarditis—Two Studies Address a Shifting Landscape

News Daily News

TAVR and Infective Endocarditis—Two Studies Address a Shifting Landscape

September 14, 2020

Blood Pressure Insights in COVID-19: Watch for Drops and RAAS Red Flags

News Conference News

Blood Pressure Insights in COVID-19: Watch for Drops and RAAS Red Flags

September 10, 2020

Inflammation Plays Into the ASCVD Risk Associated With Lp(a): ACCELERATE

News Daily News

Inflammation Plays Into the ASCVD Risk Associated With Lp(a): ACCELERATE

Michael O'Riordan

July 08, 2020

COVID-19: TCTMD’s Daily Dispatch

News Daily News

COVID-19: TCTMD’s Daily Dispatch for May

May 01, 2020

AKI After TAVR Is Decreasing, but More Efforts Needed to Prevent Stage 3

News Conference News CRT 2020

AKI After TAVR Is Decreasing, but More Efforts Needed to Prevent Stage 3

February 27, 2020

SYNTAX Score Predicts Long-term Benefits of Left Main PCI and CABG: MAIN-COMPARE

News Daily News

SYNTAX Score Predicts Long-term Benefits of Left Main PCI and CABG: MAIN-COMPARE

Michael O'Riordan

February 03, 2020

Lp(a) Reduction Contributes to Alirocumab’s Treatment Benefit: ODYSSEY Outcomes

News Daily News

Lp(a) Reduction Contributes to Alirocumab’s Treatment Benefit: ODYSSEY Outcomes

Michael O'Riordan

January 14, 2020

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.